Drug class
Lamivudine
Lamivudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs). Read more about Lamivudine
38 drugs in this class 24 manufacturers
Drugs in Lamivudine
ABACAVIR-LAMIVUDINE (abacavir sulfate/lamivudine)
DELSTRIGO (doravirine/lamivudine/tenofovir disoproxil fumarate)
LAMIVUDINE
DOVATO (dolutegravir sodium/lamivudine)
TRIUMEQ PD (abacavir sulfate/dolutegravir sodium/lamivudine)
ABACAVIR-LAMIVUDINE (abacavir sulfate/lamivudine)
EFAVIRENZ-LAMIVU-TENOFOV DISOP (efavirenz/lamivudine/tenofovir disoproxil fumarate)
LAMIVUDINE
Lamivudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs).
As a synthetic cytosine analogue, it is phosphorylated intracellularly to its active 5'-triphosphate form, which competitively inhibits viral reverse transcriptase and hepatitis B virus DNA polymerase, causing viral DNA chain termination.
Therapeutically, it is used in combination regimens to manage human immunodeficiency virus type 1 (HIV-1) infection and as a single agent or component of therapy for chronic hepatitis B virus (HBV) infection.
-
medlineplus.gov
Lamivudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs)
-
nih.gov
Lamivudine is a specific antiretroviral active pharmaceutical ingredient rather than an independent therapeutic drug class; it belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs) Therapeutically, it is used in combination regimens to manage human immunodeficiency virus type 1 (HIV-1) infection and as a single agent or component of therapy for chronic hepatitis B virus (HBV) infection
-
drugbank.com
As a synthetic cytosine analogue, it is phosphorylated intracellularly to its active 5'-triphosphate form, which competitively inhibits viral reverse transcriptase and hepatitis B virus DNA polymerase, causing viral DNA chain termination Therapeutically, it is used in combination regimens to manage human immunodeficiency virus type 1 (HIV-1) infection and as a single agent or component of therapy for chronic hepatitis B virus (HBV) infection
-
eatg.org
As a synthetic cytosine analogue, it is phosphorylated intracellularly to its active 5'-triphosphate form, which competitively inhibits viral reverse transcriptase and hepatitis B virus DNA polymerase, causing viral DNA chain termination
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.